Becker's Clinical Quality & Infection Control

September/October 2019 IC_CQ

Issue link: https://beckershealthcare.uberflip.com/i/1173622

Contents of this Issue

Navigation

Page 4 of 55

Nasal decolonization is key to reduce CP responsibly. ™ Say hello to better. Say goodbye to this. Contact precautions (CP) for MRSA colonized patients can: • be costly, time consuming • lead to isolation fatigue • adversely impact care Evidence shows Nozin makes the difference 1, 2, 3, 4 Safely reduce MRSA contact precautions Better care, patient flow and staff satisfaction 30 bed ICU could save $250k per year Lower S. aureus carriage and infection risk Rethink MRSA Active Surveillance with Universal Patient Decolonization LEADER IN NASAL DECOLONIZATION ™ 1. Deatherage N, AJIC, 2016: 44:6 (S101-S102). 2. Landis-Bogush K, Belani A, et al. AJIC, 2019: 47: 6 (S39). 3. Christie J, et al. AJIC, 2019: 47: 6 (S44 - S45) 4. Steed L, et al. AJIC, 2014: 42(8): 841-846. ©2019 Global Life Technologies Corp. All rights reserved. Made in USA. Nozin®, Nasal Sanitizer® are Global Life Technologies Corp. trademarks. Nozin Programs use nasal and body skin decolonization. Nozin® Nasal Sanitizer ® antiseptic is for nasal decolonization. Nozin® Nasal Sanitizer® antiseptic is an OTC topical drug. No claim is made that it has an eect on any specic disease. Savings estimates for example only. Any actual savings may vary. Nozin.com/say-hello Nozin advisors can help. Nozin.com 877-669-4648 Join those making a difference. Ask about Nozin programs.

Articles in this issue

Links on this page

view archives of Becker's Clinical Quality & Infection Control - September/October 2019 IC_CQ